Pharmaceutical Technology Europe
June 03, 2011
Ingredients
23
6
Effective containment in API and drug-product manufacturing encompasses a variety of process, equipment, and operational issues.
June 01, 2011
Industry Insider
23
6
The greatest challenge faced by the EMA is the continuing expansion of the EU.
June 01, 2011
Special Feature
23
6
BASF's Jan Bebber explains why immediate-release formulations boost drug efficacy and aid patient compliance.
June 01, 2011
Special Feature
23
6
The rising popularity of fast dissolving, immediate-release dosage forms can be attributed to their convenience and ease of administration.
June 01, 2011
23
6
It was a mixed crowd hosted by Dusseldorf in the middle of May.
June 01, 2011
Special Feature
23
6
When it comes to immediate-release tablet formulations, the choice of disintegrant can have a significant effect on the rate and extent of drug dissolution.
June 01, 2011
Disposables Advisor
23
6
Regions around the world are starting to follow the US trend in disposables and are working to solve common challenges.
June 01, 2011
Regulation
23
6
In January 2011, a new version of Annex 11 was released by the European Commission along with a revision of Chapter 4 of its GMP on documentation to reflect the actualities of electronic record keeping, all of which come into full effect in June 2011.
June 01, 2011
Peer-Reviewed Research
23
6
The authors compare three systems of single-screw extrusion using binary formulations for their suitability for producing pellets of various formulations and under various spheronization conditions.
June 01, 2011
Regulation
23
6
In January 2011, the European Medicines Agency (EMA) announced the new revision of EudraLex Volume 4 (GMP) - Annex 11 'Computerised Systems', and the consequential amendment of EudraLex Volume 4 - Chapter 4 ?Documentation?.